首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1741307

止吐药市场按药物类别、给药途径、分销管道和地区划分

Nausea Medicine Market, By Drug Class, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2025年03月26日 | 出版商:

Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年止吐药市场规模估计为 31.7 亿美元，预计到 2032 年将达到 48.6 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 6.3%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	31.7亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	6.30%	2032年价值预测	48.6亿美元

噁心是一种令人不安的感觉，常伴随呕吐的衝动，严重干扰日常生活。抗噁心药物是现代医疗保健的重要组成部分，旨在缓解这种痛苦的症状并改善整体健康。导致噁心和呕吐的药物是针对体内特定受体的药物。这些药物有各种剂型，包括锭剂、液体剂型和贴片。透过有效阻断受体，抗噁心药物为晕动病、化疗引起的噁心、怀孕相关不适以及其他相关疾病的患者提供了急需的缓解。在本介绍中，我们将深入探讨这些药物在改善噁心患者生活品质的重要性。

市场动态：

噁心盛行率的上升、药物配方的进步、老年人口的成长以及研发活动的活性化，预计将在预测期内推动全球抗噁心药物市场的成长。此外，认知度和诊断水准的提高也有望在预测期内推动全球抗噁心药物市场的成长。例如，2023年5月，全球生物製药公司Vanda Pharmaceuticals Inc.发表了曲吡坦（tradipitant）治疗晕动病的III期研究结果，从而证实了先前发表的研究结果，即曲吡坦有助于预防晕动病引起的呕吐。这项III期试验在美国沿海水域的一艘船上以真实环境条件进行。

然而，副作用和安全问题、止吐药高成本、缺乏针对特定原因的针对性治疗方法以及某些情况下的效率有限，预计将在预测期内阻碍全球止吐药市场的成长。

本研究的主要特点

本报告对全球止吐药市场进行了详细分析，并提供了预测期 2025-2032 的市场规模和年复合成长率（CAGR%）（假设 2024 年为基准年）。
它还揭示了各个领域的潜在商机，并解释了该市场的引人注目的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，介绍了全球止吐药市场的主要企业概况。
本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球止吐药市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员将透过用于分析全球止吐药市场的各种策略矩阵更轻鬆地做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 3.17 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.30%	2032 Value Projection:	USD 4.86 Bn

Nausea is an unsettling sensation that is often accompanied by the urge to vomit, which can significantly disrupt a daily life. Nausea medicine which is a vital aspect of modern healthcare, aims to alleviate the distressing symptom and improve overall well-being. The medicine that is designed to target body's specific receptors is responsible for nausea and vomiting. These medications come in various forms, including pills, liquids and patches. By effectively blocking the receptors, nausea medicine provides the needed relief to patients who are suffering from motion sickness, chemotherapy-included nausea, pregnancy-related discomfort, and other related conditions. This introduction delves into the importance of these medicines in enhancing quality of life for individuals plagued by nauseous episodes.

Market Dynamics:

Increasing prevalence of nausea, advancements in drug formulations and increasing geriatric population, increasing research and development activities is anticipated to drive growth of the global nausea medicine market over the forecast period. Moreover, growing awareness and diagnosis is also expected to boost the growth of the global nausea medicine market over the forecast period. Development of targeted therapies, expansion into emerging markets, combination therapies and non-pharmacological interventions are expected to create growth opportunities for the global nausea medicine market during the forecast period.For instance, in May 2023, Vanda Pharmaceuticals Inc., a worldwide biopharmaceutical company, revealed the results of its Phase III research of tradipitant in motion sickness, thereby confirming the previously published findings that tradipitant is beneficial in the prevention of motion sickness vomiting. The Phase III study was carried out on boats in U.S. coastal waters under real-world situations.

However, adverse effects and safety concerns, high cost of nausea medicines, lack of targeted therapies for specific causes and limited efficiency in some cases are expected to hamper growth of the global nausea medicine market over the forecast period.

Key features of the study:

This report provides in-depth analysis of the global nausea medicine market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global nausea medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GlaxoSmithKline plc, Pfizer Inc., Novartis International AG, Sanofi S.A., Merck & Co., Inc., Johnson & Johnson, Bayer AG, Takeda Pharmaceutical Company Limited, AstraZeneca plc, Eli Lilly and Company
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global nausea medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analysing the global nausea medicine market

Detailed Segmentation:

Global Nausea Medicine Market, By Drug Class:
- Antihistamines
- Anticholinergics
- Serotonin Antagonists
- Dopamine Antagonists
- Cannabinoids
- Others
Global Nausea Medicine Market, By Route of Administration:
- Oral
- Injectable
- Transdermal
- Rectal
- Others
Global Nausea Medicine Market, By Distribution Channel:
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Others
Global Nausea Medicine Market, By Geography:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- GlaxoSmithKline plc.
- Pfizer Inc.
- Novartis International AG
- Sanofi S.A.
- Merck & Co., Inc.
- Johnson & Johnson
- Bayer AG
- Takeda Pharmaceutical Company Limited
- AstraZeneca plc
- Eli Lilly and Company

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing prevalence of nausea
- Restraints
Adverse effects and safety concerns
- Opportunities
Development of targeted therapies
- Key Highlights
- Regulatory Scenario
- Recent Trends
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Mergers, Acquisitions, and Collaborations

4. Global Nausea Medicine Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Nausea Medicine Market, By Drug Class, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Antihistamines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Anticholinergics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Serotonin Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Dopamine Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Cannabinoids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Other
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Nausea Medicine Market, By Route of Administration, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Transdermal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Rectal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Nausea Medicine Market, By Distribution Channel, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Nausea Medicine Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
  - China
  - Japan
  - India
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 -2032, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profile
- GlaxoSmithKline plc
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Pfizer Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Novartis International AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Sanofi S.A.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Merck &Co., Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Johnson & Johnson
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Bayer AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Takeda Pharmaceutical Company Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- AstraZeneca plc
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Eli Lily and Company
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies

10. Section

References
Research Methodology
About us and Services

02-2729-4219

+886-2-2729-4219

License/价格

止吐药市场按药物类别、给药途径、分销管道和地区划分